Biointelligence™ by aveiaa helps teams assess bioequivalence feasibility before committing to full downstream work. By combining structured product inputs, regulator-aligned mechanistic modeling, dissolution intelligence, variability logic, and context-aware causal reasoning, the system identifies likely BE drivers, evidence gaps, and the most useful next actions under real-world incomplete-data conditions. It is designed not only for simulation, but also for data enrichment, evidence assembly, and explainable BE decision support.
The Knowledge Vault behind Biointelligence by aveiaa is designed to make meaningful reasoning possible even when data is incomplete, fragmented, or uneven in quality. Rather than relying only on raw user input, the Vault integrates credible regulatory sources, scientific literature, formulation and comparator intelligence, and partner property data into a structured layer of validated entity cards, causal rules, normalized datasets, and applicability-aware evidence. Through advanced context-aware causal reasoning, Biointelligence can compensate for data sparsity, identify what is missing, and still generate structured, explainable next-step guidance.